Literature DB >> 5001819

Status of adjuvant therapy: results of The National Surgical Adjuvant Breast Project studies on oophorectomy, postoperative radiation therapy, and chemotherapy. Other comments concerning clinical trials.

B Fisher.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 5001819     DOI： 10.1002/1097-0142(197112)28:6<1654::aid-cncr2820280648>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

1.  Cancer of the breast--still an enigma.

Authors:  C B Mueller
Journal:  Can Med Assoc J       Date:  1977-05-21       Impact factor: 8.262

2.  National surgical breast project.

Authors:  J R Benfield
Journal:  Calif Med       Date:  1973-03

Review 3.  The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project.

Authors:  D Lawrence Wickerham; Michael J O'Connell; Joseph P Costantino; Walter M Cronin; Soonmyung Paik; Charles E Geyer; Patricia A Ganz; Nicholas Petrelli; Eleftherios P Mamounas; Thomas B Julian; Norman Wolmark
Journal:  Semin Oncol       Date:  2008-10       Impact factor: 4.929

Review 4.  Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP).

Authors:  Priya Rastogi; D Lawrence Wickerham; Charles E Geyer; Eleftherios P Mamounas; Thomas B Julian; Norman Wolmark
Journal:  Chin Clin Oncol       Date:  2017-02

5.  DNAJB4 identified as a potential breast cancer marker: evidence from bioinformatics analysis and basic experiments.

Authors:  Linlong Mo; Jiayou Liu; Ziquan Yang; Xun Gong; Fanlun Meng; Rongyang Zou; Lingmi Hou; Fang Fang
Journal:  Gland Surg       Date:  2020-12

6.  COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer.

Authors:  Qi Luo; Jinsui Li; Xiaohan Su; Qiao Tan; Fangfang Zhou; Shaoli Xie
Journal:  Front Genet       Date:  2022-09-09       Impact factor: 4.772
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.